Your web browser is out of date. Update your browser for more security, speed and the best experience on this site.

Update your browser

When to Build vs. Buy an Enterprise Genomics Platform

This whitepaper explores the challenges CIOs encounter when deciding to build or buy technology for their enterprise company.

Omics Data Explosion

With the explosion of genomics and other omics data, existing bioinformatics systems may struggle under the size and complexity of the data. Additionally, it's hard and expensive to keep a system up-to-date and optimized, while also trying to stay ahead of new technologies.These challenges bring technical leaders back to the long-standing debate of whether to build a bioinformatics system in-house or buy from a vendor. Technical leaders are expected to identify cost-efficient and scalable solutions that balance the enterprise's immediate needs with its long-term growth. Is your bioinformatics system ready for the challenge?

This Whitepaper Includes:

  • A comprehensive overview of the Build vs. Buy debate based on an organizations needs and expectations
  • Worksheet: Is your bioinformatics system ready for the omics explosion?
  • The lure and limits of doing-it-yourself (DIY) and a checklist if you plan to go down that path
  • What to look for in a partner if considering investing in a comprehensive, extensible platform
  • Case Study: A life sciences corporation's dilemma to build or buy

I consent to the use of cookies by DNAnexus and necessary third parties in accordance to the Privacy Policy and Terms of Services. DNAnexus may use third-party services for this purpose. I can revoke my consent anytime by visiting the Cookies Settings page.